Last updated on February 2020

Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006)


Find a site near you

Start Over

Levine Cancer Institute

Charlotte, NC United States
  Connect »

Regional Cancer Care Associates

East Brunswick, NJ United States
  Connect »

Sutter Medical Center

Sacramento, CA United States
  Connect »

Northwestern University

Chicago, IL United States
  Connect »

Oncology Hematology Care

Cincinnati, OH United States
  Connect »